Cart summary

You have no items in your shopping cart.

Interleukin 6 (IL6) Monoclonal Antibody

Interleukin 6 (IL6) Monoclonal Antibody

Catalog Number: orb1921772

DispatchUsually dispatched within 5-10 working days
$ 230.00
Catalog Numberorb1921772
CategoryAntibodies
DescriptionInterleukin-6 (IL-6) is a 26 kDa secreted protein that consists of 184 amino acids with two N-glycosylation sites and four cysteine residues. It is a pleiotropic cytokine with roles in immunity, tissue regeneration, and metabolism. Rapid production of IL-6 contributes to host defense during infection and tissue injury, but excessive synthesis of IL-6 and dysregulation of IL-6 receptor signaling is involved in disease pathology.Therapeutic agents targeting the IL-6 axis are effective in rheumatoid arthritis, and applications are being extended to other settings of acute and chronic inflammation. The IL-6 signaling cascade is initiated by binding of IL-6 to IL-6R and a second transmembrane protein, gp130, which serves as a signal transducer of IL-6. Although IL-6R expression is restricted to cells such as hepatocytes, monocytes, and lymphocytes, gp130 is ubiquitously expressed, potentially explaining the pleiotropic functions of IL-6. Unlike gp130, IL-6R exists in an 80 kDa transmembrane form and a 50-55 kDa soluble form (sIL-6R). Classic IL-6R signaling is thought to be anti-inflammatory and mediated by membrane-bound IL-6R (mIL-6R) and gp130. Classical IL-6 signaling only occurs on some subsets of T cells, hepatocytes, megakaryocytes, neutrophils and monocytes. Additionally, IL-6 can also bind to sIL-6R and the IL-6-sIL-6R complex then binds to membrane-bound gp130 on cells that do not express IL-6R on the surface, a process known as trans-signaling. In both classical and trans-signaling, the IL-6/IL-6R/gp130 complex activates intracellular signaling through the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway and the mitogen-activated protein kinase (MAPK) pathway. There is evidence that an imbalance away from the MAPK pathway via removal of regulation by suppressor of cytokine signaling 3 (SOCS3) towards the pro-inflammatory STAT3 signaling pathway contributes to autoimmune disease and therefore may also be a target for stress susceptibility.
ClonalityMonoclonal
Species/HostMouse
ConjugationUnconjugated
Form/AppearancePurified,Liquid
Purity> 95% pure (SDS-PAGE).
MW150 kDa
Tested applicationsCLIA, LF
Application notesRecommended Applications: LFIA , CLIA. Test Methods: Test Linear Range, Test Detection Limit
Matched PairsCapture: orb2280030; Detection: orb1921772
Sample TypesTest sample type: Serum / Plasma. Test sample source: Human
StorageFor long term storage, the product should be stored at -20°C or lower.
Alternative namesIL6-mAb
NoteFor research use only
  • Anti-SP1 Antibody (monoclonal, 3C4C3) [orb1474870]

    FC,  ICC,  IF,  IHC,  WB

    Human

    Mouse

    Monoclonal

    Unconjugated

    10 μg, 100 μg
  • Anti-PCNA Antibody (monoclonal, 2G2) [orb865596]

    FC,  ICC,  IF,  IHC,  WB

    Human, Mouse, Rat

    Mouse

    Monoclonal

    Unconjugated

    10 μg, 100 μg
  • Anti-PARP/PARP1 Antibody (monoclonal, 2I2H4) [orb738400]

    FC,  ICC,  IF,  IHC,  WB

    Human, Mouse, Rat

    Mouse

    Monoclonal

    Unconjugated

    10 μg, 100 μg
  • Anti-PARP/PARP1 Antibody (monoclonal, 10G9) [orb738402]

    FC,  ICC,  IF,  IHC,  WB

    Human, Mouse, Rat

    Mouse

    Monoclonal

    Unconjugated

    10 μg, 100 μg
  • Anti-PARP/PARP1 Antibody (monoclonal, 10E11) [orb738401]

    FC,  ICC,  IF,  IHC,  WB

    Human, Mouse, Rat

    Mouse

    Monoclonal

    Unconjugated

    10 μg, 100 μg